Achira Labs
Bangalore, India· Est.
Fast, quantitative POC diagnostics powered by microfluidics and lateral‑flow technology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Fast, quantitative POC diagnostics powered by microfluidics and lateral‑flow technology.
FertilityEndocrinologyRespiratoryNephrologyImmunologyCardiology
Technology Platform
Patented hydrogel‑based microfluidic cartridge (μFluidix) for multiplex quantitative analysis and a lateral‑flow reader (QuantALFA) that converts rapid tests into quantitative digital results.
Opportunities
Expansion into emerging markets and development of custom multiplex panels for infectious diseases and chronic conditions can drive revenue growth.
Risk Factors
Regulatory approvals in new geographies, competition from established POC manufacturers, and adoption hurdles in resource‑limited settings pose significant risks.
Competitive Landscape
Competes with Abbott, Roche, Siemens, and other POC providers; differentiation stems from hydrogel‑based multiplexing, rapid quantitative readouts, and an integrated digital ecosystem.